Philip Werthman

Dr. Philip Werthman, M.D., MMH is director of the Center for Male Reproductive Medicine, and former assistant clinical professor of urology at the University of Southern California School of Medicine. Dr. Werthman received his medical degree from Hahnemann University School of Medicine in Philadelphia, graduating valedictorian. Dr. Werthman completed his residency and fellowship in urology at the University of California, Los Angeles (UCLA). He conducted award-winning early research in the field of gene therapy for urologic cancers and innovated a number of microsurgical procedures used today. Dr. Werthman founded Merkava Holdings, a venture capital and advisory company focused on helping grow early stage platform life sciences technologies with expertise in biopharma and medical devices. He currently serves as chairman of the boards of Rithem Life Sciences, LLC and Proxamama Inc. and is a board member or strategic advisor to multiple companies.